Tamoxifen induced non-alcoholic steatohepatitis (NASH) - a case report and its clinical implications
dc.contributor.author | Satarasinghe, R.L. | en_US |
dc.contributor.author | Bulugahapitiya, U. | en_US |
dc.contributor.author | Fernando, H.R.R. | en_US |
dc.date.accessioned | 2013-11-27T06:30:42Z | |
dc.date.available | 2013-11-27T06:30:42Z | |
dc.date.issued | 2003 | en_US |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 36(1-2):p.53-55 | en_US |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/10113 | |
dc.publisher | Ceylon College of Physicians. Rajagiriya | en_US |
dc.subject | Medical Sciences | en_US |
dc.subject | Non-alcoholic steatohepatitis | en_US |
dc.subject | Carcinoma | en_US |
dc.subject | Drug therapy | en_US |
dc.subject | Disease management | en_US |
dc.subject | Case reports | en_US |
dc.title | Tamoxifen induced non-alcoholic steatohepatitis (NASH) - a case report and its clinical implications | en_US |
dc.type | A | en_US |